---
schema_version: "secwatch.filing_event.v1"
accession: "0001522767-24-000005"
form_type: "8-K"
ticker: "MRMD"
cik: "0001522767"
company_name: "MARIMED INC."
filed_at: "2024-03-06T23:59:59+00:00"
generated_at: "2026-06-05T02:35:52.621082+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# MariMed Q4 revenue $38.9M (+8.6% YoY); GAAP net loss $10.1M; announces MD dispensary acquisition

## Summary
- Q4 2023 revenue $38.9M, up 8.6% from $35.8M in Q4 2022; full year revenue $148.6M, up 10.9% from $134.0M.
- GAAP net loss of $10.1M in Q4 vs net income of $4.8M in prior year; full year net loss $16.0M vs net income $13.6M.
- Non-GAAP adjusted EBITDA $5.2M in Q4 (14% margin) vs $4.5M in Q4 2022; full year $24.7M (17% margin) vs $32.4M (24% margin).
- Company announces pending acquisition of a dispensary in Upper Marlboro, Maryland, expanding its footprint in the state.
- CEO cites sixth consecutive year of double-digit revenue growth and positive adjusted EBITDA; wholesale operations in Illinois contributing to 2024.

## SEC filing metadata
- accession: 0001522767-24-000005
- form_type: 8-K
- ticker: MRMD
- cik: 0001522767
- company_name: MARIMED INC.
- filed_at: 2024-03-06T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1522767/000152276724000005/0001522767-24-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1522767/000152276724000005/mrmd-20240306.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001522767-24-000005
- JSON: https://secwatch.observer/filing/0001522767-24-000005.json
- Plain text: https://secwatch.observer/filing/0001522767-24-000005.txt

## Key facts
- Earnings Releases
  MARIMED INC. reported financial results for the fourth quarter and year ended December 31, 2023.
  - Period: the fourth quarter and year ended December 31, 2023
  - Result: reported results
  source text: On March 6, 2024, MariMed Inc. (the “Company”) issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference, announcing its financial results for the three months and year ended December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1522767/000152276724000005/0001522767-24-000005-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.